CeloNova BioSciences Announces World's First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Mi... (clinicaloutcomes and the real-world need...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> BIOLOGY >> TECHNOLOGY

CeloNova BioSciences Announces World's First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres

Date:9/8/2007

clinical outcomes and the real-world needs of physicians and operating room staff in mind. Embozene(TM) Color-Advanced Microspheres represent the embodiment of that philosophy in action; color-coding improves patient safety while simplifying the job of those performing the procedure."

Embozene(TM) Color-Advanced Microspheres are the next evolution in an embolic platform and are available either in vials or pre-filled syringes depending on physician preference.

About CeloNova BioSciences, Inc.

Headquartered near Atlanta, Georgia, CeloNova BioSciences, Inc., is a developer of novel medical devices based on the company's patented Polyzene(R)-F surface coating technology. Polyzene(R)-F is highly lubricious, and possesses both anti-bacterial and anti-inflammatory properties that make it an ideal surface treatment for implanted medical devices. The company's current product portfolio includes its Embozene(TM) Microspheres, used to treat arteriovenous malformations, hypervascularized tumors, uterine fibroids and hepatocellular carcinoma. Other innovative devices are currently in the company's developmental pipeline. For more information, please visit http://www.celonova.com.

Thomas A. Gordy

President and Chief Executive Officer

+1 770-502-0304

SOURCE CeloNova BioSciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. Perscitus Biosciences secures $250K Commerce loan
2. Wisconsin biosciences rise to the challenge
3. Quintessence Biosciences advances cancer drug
4. Quintessence Biosciences names new president
5. Caden Biosciences may signal critical mass
6. Wisconsin start up Primorigen Biosciences corrals out-of-state investment
7. WARF signs licensing pact with BD Biosciences
8. Fisher Biosciences contracts with Madison-based GenTel BioSurfaces
9. State awards QRG Biosciences development grant
10. EMD Biosciences partners with European biotech company
11. Quintessence Biosciences forms cancer therapeutic advisory board

Post Your Comments:

Breaking Biology Technology:Successful Stem Cell Therapy for Treatment of Eye Disease 2 Successful Stem Cell Therapy for Treatment of Eye Disease 3 Successful Stem Cell Therapy for Treatment of Eye Disease 4 China Biologic Products to Ring NASDAQ Opening Bell 2 China Biologic Products to Ring NASDAQ Opening Bell 3 Biomatrica Launches SampleWare 3.1 2 Biomatrica Launches SampleWare 3.1 3 YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 2 YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 3 YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 4 YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 5

[0] Successful Stem Cell Therapy for Treatment of Eye Disease [0] China Biologic Products to Ring NASDAQ Opening Bell [0] Biomatrica Launches SampleWare 3.1 [0] YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES

Other Biology Technology:Global Internet branding of technology companies 2 Global Internet branding of technology companies 3 Is corporate branding key for IPOs? 2 Is corporate branding key for IPOs? 3

Global Internet branding of technology companies Tech Digest: Commerce, business-plan contest, tech grants, Metavante Is corporate branding key for IPOs?

Breaking Biology News(10 mins):Study reveals H1N1 unexpected weakness 2 Nanomedicine: Ending 'hit and miss' design 2 Nanomedicine: Ending 'hit and miss' design 3 From fruit fly wings to heart failure -- why Not(ch)? 2 Alliance for Regenerative Medicine Launches 50538 1 Alliance for Regenerative Medicine Launches 50538 2 New Review on PROSTVAC 28TM 29 Published by Key Investigators From NCI 4673 1 New Review on PROSTVAC 28TM 29 Published by Key Investigators From NCI 4673 2 Both good bad movie characters who smoke influence teens to do the same 50531 1 Both good bad movie characters who smoke influence teens to do the same 50531 2

[0] Study reveals H1N1 unexpected weakness [0] Nanomedicine: Ending 'hit and miss' design [0] From fruit fly wings to heart failure -- why Not(ch)?

Other Biology News:Diatoms discovered to remove phosphorus from oceans 2 Wiley-Blackwell to launch Journal of Flood Risk Management 2 Bees disease -- 1 step closer to finding a cure 2

Diatoms discovered to remove phosphorus from oceans Wiley-Blackwell to launch Journal of Flood Risk Management Bees disease -- 1 step closer to finding a cure

Biology Products:

Jewett plasma and blood bank freezers from Thermo Scientific SuperScript III RNase H- Reverse Transcriptase from Invitrogen 4" Riser for 16" Tanks (for use with 4000108 and 4000109) from Thermo Scientific Rapid DNA Ligation Kit from Roche Applied Science